UNSPSC 85694631: Supplement left finger phalanx with nonautologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left finger phalanx with nonautologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0PUV0KZ

UNSPSC 85694631 Supplement left finger phalanx with nonautologous tissue substitute, open approach is a Commodity code that shows minimal relevance to recent state and local procurement activity. The code nominates a specific orthopedic surgical procedure — augmentation of a finger bone with synthetic material — yet the recent opportunities posted under this code span occupational health surveillance, pharmacy benefit management, temporary health professional staffing, independent disability medical evaluations, surgical benefits carve-out programs, and juvenile detention healthcare services. None of these solicitations involve finger phalanx supplementation or implantable tissue substitutes. The mismatch suggests either a taxonomy coding error in the source data or incidental application of this code to health services RFPs that do not reflect the code's stated scope.

The source records no recent state and local procurement opportunities that actually solicit finger phalanx supplementation services or related orthopedic implant procedures. The issuing bodies named — the City of Phoenix Retirement Office, City of Long Beach, Washington State Department of Transportation, Harris County Juvenile Probation Department, Collier County Board of County Commissioners, and Santa Clara County Health System — are soliciting administrative health services, workforce staffing, and benefits management, not surgical procedures or device procurement. This code warrants monitoring only if the source's tagging corrections it or if future opportunities align with orthopedic surgical implant procurement by state or local health systems, hospital authorities, or employee health benefits programs.